Good evening :)
Place Order
Add to Watchlist

Zenlabs Ethica Ltd

ZENLABS Share Price

32.950.18% (-0.06)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹21 cr, stock is ranked 4,144

High Risk

Stock is 3.67x as volatile as Nifty

ZENLABS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹21 cr, stock is ranked 4,144

High Risk

Stock is 3.67x as volatile as Nifty

ZENLABS Performance & Key Metrics

ZENLABS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
76.752.12—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.026.630.84%

ZENLABS Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ZENLABS Company Profile

Zenlabs Ethica, formerly Neelkanth Technologies Limited, is a pharmaceutical company engaged in trading/marketing in pharmaceutical products

ZENLABS Similar Stocks (Peers)

Compare with peers Compare with peers 

ZENLABS Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.08
37.08
1Y Return
12.73%
12.73%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
23.14
23.14
1Y Return
0.56%
0.56%
Buy Reco %
74.19
74.19
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.85
19.85
1Y Return
11.86%
11.86%
Buy Reco %
56.67
56.67
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
57.05
57.05
1Y Return
12.44%
12.44%
Buy Reco %
72.00
72.00
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
21.83
21.83
1Y Return
9.78%
9.78%
Buy Reco %
48.28
48.28
Compare with Peers

ZENLABS Forecast

ZENLABS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

ZENLABS

ZENLABS

Income

Balance Sheet

Cash Flow

ZENLABS Income Statement

ZENLABS Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -2.69%, vs industry avg of 9.02%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.03% to 0.02%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -19.47%, vs industry avg of 15.29%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue81.2471.9467.4660.0056.7669.1867.0258.8651.4751.48
Raw Materialssubtract63.3852.7954.7249.6147.3159.8656.0244.4148.8548.85
Power & Fuel Costsubtract0.030.020.030.040.050.040.030.04
Employee Costsubtract3.052.803.283.243.423.904.334.46
Selling & Administrative Expensessubtract10.609.038.987.564.426.006.147.53
Operating & Other expensessubtract2.655.35-1.740.20-0.30-3.15-1.96-0.29
Depreciation/Amortizationsubtract0.200.200.230.290.710.891.251.291.261.26
Interest & Other Itemssubtract0.100.090.070.230.290.370.530.830.930.93
Taxes & Other Itemssubtract0.270.490.62-0.430.090.440.180.160.160.16
EPS1.471.801.95-1.141.181.270.770.660.410.43
DPS0.240.000.000.000.000.000.250.000.000.00
Payout ratio0.160.000.000.000.000.000.330.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

ZENLABS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

ZENLABS Stock Peers

ZENLABS Past Performance & Peer Comparison

ZENLABS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Zenlabs Ethica Ltd79.592.12—
Sun Pharmaceutical Industries Ltd37.086.040.95%
Cipla Ltd23.144.551.06%
Dr Reddy's Laboratories Ltd19.853.970.59%

ZENLABS Stock Price Comparison

Compare ZENLABS with any stock or ETF
Compare ZENLABS with any stock or ETF
ZENLABS
Loading...

ZENLABS Holdings

ZENLABS Shareholdings

ZENLABS Promoter Holdings Trend

ZENLABS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ZENLABS Institutional Holdings Trend

ZENLABS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ZENLABS Shareholding Pattern

ZENLABS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding52.96%0.00%0.00%0.00%47.04%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

ZENLABS Shareholding History

ZENLABS Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

ZENLABS Insider Trades & Bulk Stock Deals

ZENLABS Insider Trades & Bulk Stock Deals

Loading...

smallcases containing ZENLABS stock

smallcases containing ZENLABS stock

Looks like this stock is not in any smallcase yet.

ZENLABS Events

ZENLABS Events

ZENLABS Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

ZENLABS Dividend Trend

No dividend trend available

ZENLABS Upcoming Dividends

ZENLABS Upcoming Dividends

No upcoming dividends are available

ZENLABS Past Dividends

ZENLABS Past Dividends

Cash Dividend

Ex DateEx DateJul 29, 2022

Interim
Interim | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Jul 29, 2022

Cash Dividend

Ex DateEx DateSep 20, 2017

Final
Final | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Sep 20, 2017

ZENLABS Stock News & Opinions

ZENLABS Stock News & Opinions

Earnings
Zenlabs Ethica standalone net profit declines 40.00% in the March 2025 quarter

Net profit of Zenlabs Ethica declined 40.00% to Rs 0.09 crore in the quarter ended March 2025 as against Rs 0.15 crore during the previous quarter ended March 2024. Sales declined 15.26% to Rs 12.99 crore in the quarter ended March 2025 as against Rs 15.33 crore during the previous quarter ended March 2024. For the full year,net profit declined 35.71% to Rs 0.27 crore in the year ended March 2025 as against Rs 0.42 crore during the previous year ended March 2024. Sales declined 12.19% to Rs 51.42 crore in the year ended March 2025 as against Rs 58.56 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales12.9915.33 -15 51.4258.56 -12 OPM %5.084.96 -5.004.10 - PBDT0.470.53 -11 1.691.87 -10 PBT0.160.20 -20 0.430.58 -26 NP0.090.15 -40 0.270.42 -36 Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Zenlabs Ethica standalone net profit declines 18.18% in the December 2024 quarter

Net profit of Zenlabs Ethica declined 18.18% to Rs 0.09 crore in the quarter ended December 2024 as against Rs 0.11 crore during the previous quarter ended December 2023. Sales declined 18.46% to Rs 12.72 crore in the quarter ended December 2024 as against Rs 15.60 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.7215.60 -18 OPM %5.424.42 - PBDT0.450.47 -4 PBT0.130.15 -13 NP0.090.11 -18 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Zenlabs Ethica standalone net profit declines 44.44% in the September 2024 quarter

Net profit of Zenlabs Ethica declined 44.44% to Rs 0.05 crore in the quarter ended September 2024 as against Rs 0.09 crore during the previous quarter ended September 2023. Sales declined 5.05% to Rs 13.35 crore in the quarter ended September 2024 as against Rs 14.06 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales13.3514.06 -5 OPM %4.573.13 - PBDT0.380.45 -16 PBT0.070.13 -46 NP0.050.09 -44 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Zenlabs Ethica to announce Quarterly Result

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Zenlabs Ethica AGM scheduled

Zenlabs Ethica announced that the 31th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Zenlabs Ethica standalone net profit declines 42.86% in the June 2024 quarter

Net profit of Zenlabs Ethica declined 42.86% to Rs 0.04 crore in the quarter ended June 2024 as against Rs 0.07 crore during the previous quarter ended June 2023. Sales declined 8.92% to Rs 12.36 crore in the quarter ended June 2024 as against Rs 13.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.3613.57 -9 OPM %5.023.91 - PBDT0.390.42 -7 PBT0.070.10 -30 NP0.040.07 -43 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Zenlabs Ethica announces board meeting date

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Zenlabs Ethica Ltd (ZENLABS) today?

    The share price of ZENLABS as on 11th June 2025 is ₹32.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Zenlabs Ethica Ltd (ZENLABS) share?

    The past returns of Zenlabs Ethica Ltd (ZENLABS) share are
    • Past 1 week: -3.48%
    • Past 1 month: -1.02%
    • Past 3 months: 4.99%
    • Past 6 months: -18.80%
    • Past 1 year: -24.65%
    • Past 3 years: -5.87%
    • Past 5 years: 37.67%

  3. What are the peers or stocks similar to Zenlabs Ethica Ltd (ZENLABS)?

    The peers or stocks similar to Zenlabs Ethica Ltd (ZENLABS) include:

  4. What is the market cap of Zenlabs Ethica Ltd (ZENLABS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenlabs Ethica Ltd (ZENLABS) is ₹21.49 Cr as of 11th June 2025.

  5. What is the 52 week high and low of Zenlabs Ethica Ltd (ZENLABS) share?

    The 52-week high of Zenlabs Ethica Ltd (ZENLABS) is ₹52.10 and the 52-week low is ₹27.33.

  6. What is the PE and PB ratio of Zenlabs Ethica Ltd (ZENLABS) stock?

    The P/E (price-to-earnings) ratio of Zenlabs Ethica Ltd (ZENLABS) is 79.59. The P/B (price-to-book) ratio is 2.12.

  7. Which sector does Zenlabs Ethica Ltd (ZENLABS) belong to?

    Zenlabs Ethica Ltd (ZENLABS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Zenlabs Ethica Ltd (ZENLABS) shares?

    You can directly buy Zenlabs Ethica Ltd (ZENLABS) shares on Tickertape. Simply sign up, connect your demat account and place your order.